GeneGo Lands $336K SBIR Grant | GenomeWeb

NEW YORK (GenomeWeb News) – GeneGo has won a $336,000 grant from the National Institute of General Medical Sciences, which it plans to use to create new types of signatures for drug resistance, the company said today.

GeneGo will use the Phase I Small Business Innovation Research grant in a collaboration with the Van Andel Institute for Translational Medicine that will focus on using GeneGo’s database and algorithms to identify key proteins in signaling networks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.